Results 171 to 180 of about 21,764,403 (203)
Some of the next articles are maybe not open access.

On the Biopharmaceutics Classification System Biowaiver of Ibuprofen

Journal of Pharmaceutical Sciences, 2015
1Division of Pharmacology and Clinical Evaluation, Department of Human Use Medicines, Spanish Agency for Medicines and Health Care Products, Madrid, Spain 2Division of Biopharmaceutics Evaluation, Bureau of Pharmaceutical Sciences, Therapeutic Products Directorate, Health Canada, Ottawa, Canada 3Subdepartment of Biostatistics and Pharmacokinetics ...
Alfredo, García-Arieta   +2 more
openaire   +2 more sources

Impact of Biopharmaceutics Classification System-Based Biowaivers

Molecular Pharmaceutics, 2010
The Biopharmaceutics Classification System (BCS) is employed to waive in vivo bioequivalence testing (i.e. provide "biowaivers") for new and generic drugs that are BCS class I. Granting biowaivers under systems such as the BCS eliminates unnecessary drug exposures to healthy subjects and provides economic relief, while maintaining the high public ...
Jack A, Cook   +2 more
openaire   +2 more sources

Biowaiver and Biopharmaceutics Classification System

2014
Biowaiver is defined as FDA waiving the requirement for the in vivo bioavailability/bioequivalence studies. This chapter discusses the following biowaivers: (a) For drug products where bioavailability is self-evident e.g., solutions, (b) Biowaivers in situations where one can rely on in vitro methods instead of in vivo for assessing bioavailability ...
Ramana S. Uppoor   +3 more
openaire   +1 more source

Considerations for application of biopharmaceutics classification system in chicken: Exemplified by seven drugs classification

Journal of Veterinary Pharmacology and Therapeutics, 2020
AbstractBiopharmaceutics Classification System (BCS) has gained broad acceptance in promoting the development of human drugs. To date, the applicability of existing human BCS criteria has not been evaluated in chickens. The objective of this study was to discuss the feasibility of BCS extrapolation between species and establish a preliminary chicken ...
Yang Liu   +5 more
openaire   +2 more sources

A New Computational Approach to the Classification of Fluoroquinolones According to the Biopharmaceutical Classification System

Current Computer Aided-Drug Design, 2017
Two main factors, which have an influence on oral absorption from solid, immediate release dosage form, are solubility and permeability. These are considered the main fundamental properties that govern the rate and extent of oral absorption. The significance of these properties has been highlighted in the Biopharmaceutics Classification System (BCS ...
Kłosińska-Szmurło, Ewa   +3 more
openaire   +2 more sources

A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: A cross-sectional survey with 500 bioequivalence studies

Journal of Pharmaceutical Sciences, 2013
Although policies of waiving bioequivalence studies are part of the legal framework of various regulatory agencies, there is no harmonization with regard to extension of the biowaiver to drugs other than those with high solubility and high permeability, nor is there any consensus or official endorsement of the biopharmaceutics drug disposition ...
Rodrigo, Cristofoletti   +3 more
openaire   +2 more sources

Cyclodextrins and the Biopharmaceutics Classification System of Drugs

Journal of inclusion phenomena and macrocyclic chemistry, 2002
Although the biopharmaceutics classification system (BCS) was originally developed for solid oral dosage forms this system can be extended to other types of drug delivery forms. According to the BCS aqueous solubility and permeability are the most important parameters affecting drug bioavailability.
openaire   +1 more source

Oral drug absorption and the Biopharmaceutics Classification System

Journal of Drug Delivery Science and Technology, 2007
Bioavailability (BA) and bioequivalence (BE) play a central role in pharmaceutical product development and BE studies are presently being conducted for New Drug Application (NDAs) of new compounds, in supplementary NDAsfor new medical indications and product line extensions, in Abbreviated New Drug Applications (ANDAs) of generic products and in ...
H. Lennernäs   +3 more
openaire   +1 more source

Pharmaceutical product development technologies based on the biopharmaceutical classification system

Die Pharmazie, 2009
Poor solubility and poor permeability account for many pharmacokinetic failures and about thirty percent of drug molecules are rejected due to pharmacokinetic failures. When poor pharmaceutical properties are discovered in development, the cost of bringing a potent, but poorly absorbable molecule to the product stage by formulation can become very high.
Pathak, D., Jain, D., Pathak, K.
openaire   +2 more sources

The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation Development

Journal of Pharmaceutical Sciences, 2010
A revised classification system for oral drugs was developed using the biopharmaceutics classification system (BCS) as a starting point. The revised system is designed to have a greater focus on drug developability. Intestinal solubility, the compensatory nature of solubility and permeability in the small intestine and an estimate of the particle size ...
James M, Butler, Jennifer B, Dressman
openaire   +2 more sources

Home - About - Disclaimer - Privacy